Page 3 - கிளாக்சோஸ்மித்க்லைன் சனோஃபி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 Vaccination for People Living With HIV: What Do We Know So Far? Bill Oxford via iStock Shipments of the first COVID-19 vaccine began moving across the U.S. on Dec. 13, less than 48 hours after the U.S. Food and Drug Administration (FDA) issued an emergency authorization for its use. By Dec. 14, a select group of Americans had begun receiving it. The first vaccine doses are reserved for two prioritized groups: 1) staff and residents of long-term care facilities and 2) health care workers likely to be exposed to the virus. Beyond sighs of relief and joy at the remarkable feat of creating what appears to be a highly effective coronavirus vaccine within a year of the start of the pandemic, the emergency authorization of two COVID-19 vaccines this month one from Pfizer-BioNTech and one from Moderna has many people living with HIV (PLWH) asking where they might fall in the inoculation queue and whether the vaccine is safe for them to receive.

United statesNew yorkSouth africaUnited kingdomTim hornMurray pennerLynda deeSarah mbaeyiGlaxosmithkline sanofiCenters for diseaseTreatment action groupDrug administrationAdvisory committee on immunization practicesAmerican medical associationLatino commissionPrevention access campaign